Angiodynamics, Inc. · NASDAQ:ANGO
Angiodynamics — Q4 2018 Earnings Presentation
10 slides from Angiodynamics's earnings presentation, Jul 11, 2018
Slide 1: AngioDynamics Fourth Quarter 2018 Earnings Presentation
AngioDynamics Fourth Quarter 2018 Earnings PresentationJuly 11, 2018
Slide 2: Forward-Looking Statement
2 Forward-Looking Statement Notice Regarding Forward-Looking StatementsThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics’ expected future financial position, results of operations,
Slide 3: Fourth Quarter 2018 Highlights
Fourth Quarter 2018 Highlights Financial Performance Revenue of $88.3 million, up 1.6% year over year (excluding the $2.6 million Acculis recall reserve from FY’17, sales were down $1.2 million)Gross Margin ended at 53.7%, up 500 bps year over year (excluding the Acculis recall reserve (Revenue and
Slide 4: Fourth Quarter and Fiscal Year 2018 Results
Fourth Quarter and Fiscal Year 2018 Results $ in millions (except per share data) FY2018Q4 Results FY2017Q4 Results Change FY2018Results FY2017Results Change Revenue- Peripheral Vascular- Vascular Access- Oncology/Surgery - United States- International $88.352.623.612.170.318.0 $86.953.924.28.870.81
Slide 5: Detail for Select Income Statement Line Items
Detail for Select Income Statement Line Items $ in millions FY2018 FY2017 Contingent Consideration:Adjustment to minimum milestone payments on AngioVacWrite-off of TiLo related contingent payments based on regulatory milestonesAmortization related to remaining minimum paymentsTotal --$0.3$0.3 ($13.4
Slide 6: 2019 Outlook
2019 Outlook Operational Excellence Gross margin expansion and stabilityTargeted R&D focused on ROICommitment to quality and complianceContinue to drive operating leverage Value Creation Practice dispassionate portfolio optimization Focus on areas of compelling unmet needs - patient-centric/evidence
Slide 7: GAAP to Non-GAAP Reconciliation
GAAP to Non-GAAP Reconciliation
Slide 8: Reconciliation of GAAP to Non-GAAP Gross Profit, Net Income and EPS
Reconciliation of GAAP to Non-GAAP Gross Profit, Net Income and EPS
Slide 9: Reconciliation of Net Income to EBITDAS to Adjusted EBITDAS
Reconciliation of Net Income to EBITDAS to Adjusted EBITDAS
Slide 10: Growth through Focus, Execution, Accountability
Growth through Focus Execution Accountablity ® angiodynamics